RT Journal Article
T1 Impact of the use of small-area models on estimation of attributable mortality at a regional level
A1 Rey Brandariz, Julia
A1 Santiago Pérez, María Isolina
A1 Candal Pedreira, Cristina
A1 Varela Lema, María Leonor
A1 Ruano Raviña, Alberto
A1 López Vizcaíno, María Esther
A1 Guerra Tort, Carla
A1 Ahluwalia, Jasjit S.
A1 Montes-Martínez, Agustín
A1 Pérez Ríos, Mónica
K1 Smoking
K1 Cause of death
K1 Health surveys
K1 Spain
K1 Mortality
K1 Tobacco use
AB The objective of this study is to assess the impact of applying prevalences derived from a small-area model at a regional level on smoking-attributable mortality (SAM). A prevalence-dependent method was used to estimate SAM. Prevalences of tobacco use were derived from a small-area model. SAM and population attributable fraction (PAF) estimates were compared against those calculated by pooling data from three national health surveys conducted in Spain (2011–2014–2017). We calculated the relative changes between the two estimates and assessed the width of the 95% CI of the PAF. Applying surveys-based prevalences, tobacco use was estimated to cause 53 825 (95% CI: 53 182–54 342) deaths in Spain in 2017, a figure 3.8% lower obtained with the small-area model prevalences. The lowest relative change was observed in the Castile-La Mancha region (1.1%) and the highest in Navarre (14.1%). The median relative change between regions was higher for women (26.1%), population aged ≥65 years (6.6%), and cardiometabolic diseases (9.0%). The differences between PAF by cause of death were never greater than 2%. Overall, the differences between estimates of SAM, PAF, and confidence interval width are small when using prevalences from both sources. Having these data available by region will allow decision-makers to implement smoking control measures based on more accurate data
PB Oxford Academic
SN 1101-1262
YR 2024
FD 2024-06-21
LK http://hdl.handle.net/10347/34850
UL http://hdl.handle.net/10347/34850
LA eng
NO European Journal of Public Health, 2024, ckae104
NO This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project ‘PI19/00288’ and co-funded by European Union
DS Minerva
RD 24 abr 2026